These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9703307)

  • 1. Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis.
    Schreiner SA; Gorman B; Stephens DH
    Mayo Clin Proc; 1998 Aug; 73(8):780-3. PubMed ID: 9703307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis.
    Young ST; Paulson EK; Washington K; Gulliver DJ; Vredenburgh JJ; Baker ME
    AJR Am J Roentgenol; 1994 Dec; 163(6):1385-8. PubMed ID: 7992734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings.
    Shirkhoda A; Baird S
    Abdom Imaging; 1994; 19(1):39-42. PubMed ID: 8161901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis with steatohepatitis after adjuvant tamoxifen.
    Oien KA; Moffat D; Curry GW; Dickson J; Habeshaw T; Mills PR; MacSween RN
    Lancet; 1999 Jan; 353(9146):36-7. PubMed ID: 10023952
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen-induced submassive hepatic necrosis.
    Storen EC; Hay JE; Kaur J; Zahasky K; Hartmann L
    Cancer J; 2000; 6(2):58-60. PubMed ID: 11069218
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy.
    Nishino M; Hayakawa K; Nakamura Y; Morimoto T; Mukaihara S
    AJR Am J Roentgenol; 2003 Jan; 180(1):129-34. PubMed ID: 12490491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
    Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
    Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
    Dray X; Tainturier MH; De La Lande P; Marty O; Mallet L
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1122-3. PubMed ID: 11139682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education and imaging. Hepatobiliary and pancreatic: Pseudocirrhosis after chemotherapy.
    Liu CH; Chao TY
    J Gastroenterol Hepatol; 2011 Apr; 26(4):788. PubMed ID: 21418309
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.
    Murata Y; Ogawa Y; Saibara T; Nishioka A; Takeuchi N; Kariya S; Onishi S; Yoshida S
    Oncol Rep; 2003; 10(1):97-100. PubMed ID: 12469151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
    Prokasheva S; Faran Y; Cwikel J; Geffen DB
    J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy.
    Maruyama S; Hirayama C; Abe J; Tanaka J; Matsui K
    Dig Dis Sci; 1995 Dec; 40(12):2602-7. PubMed ID: 8536519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
    Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
    Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
    Sestak I; Cuzick J; Sapunar F; Eastell R; Forbes JF; Bianco AR; Buzdar AU;
    Lancet Oncol; 2008 Sep; 9(9):866-72. PubMed ID: 18703382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
    Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
    Lancet; 1999 May; 353(9166):1802. PubMed ID: 10348023
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy, oestrogens and hair loss.
    Messenger AG
    Br J Dermatol; 2014 Mar; 170(3):493-4. PubMed ID: 24617428
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer.
    Jaspers H; Blaisse R; Maessen-Visch B; Mattijssen V
    Neth J Med; 2009 Jun; 67(6):245-6. PubMed ID: 19749398
    [No Abstract]   [Full Text] [Related]  

  • 19. Cirrhosis: CT and MR imaging evaluation.
    Brancatelli G; Federle MP; Ambrosini R; Lagalla R; Carriero A; Midiri M; Vilgrain V
    Eur J Radiol; 2007 Jan; 61(1):57-69. PubMed ID: 17145154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases.
    Nascimento AB; Mitchell DG; Rubin R; Weaver E
    Radiology; 2001 Oct; 221(1):117-21. PubMed ID: 11568328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.